B-Cell CLL/lymphoma 6, Member B (BCL6B) (Middle Region) Peptide
BCL6B
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits BCL6B
- BCL6B (B-Cell CLL/lymphoma 6, Member B (BCL6B))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-BCL6B antibody (Catalog #: ARP40045_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- BCL6B (B-Cell CLL/lymphoma 6, Member B (BCL6B))
- Synonymes
- BAZF Peptide, ZBTB28 Peptide, ZNF62 Peptide, Bazf Peptide, RGD1563179 Peptide, B-cell CLL/lymphoma 6B Peptide, B cell CLL/lymphoma 6, member B Peptide, B-cell CLL/lymphoma 6, member B Peptide, BCL6B Peptide, Bcl6b Peptide, bcl6b Peptide
- Sujet
-
BCL6B acts as a sequence-specific transcriptional repressor in association with BCL6. BCL6B may function in a narrow stage or be related to some events in the early B-cell development.
Alias Symbols: BAZF, ZBTB28, ZNF62
Protein Interaction Partner: BCL6
Protein Size: 480 - Poids moléculaire
- 52 kDa
- ID gène
- 255877
- NCBI Accession
- NM_181844, NP_862827
- UniProt
- Q8N143
-
Vous êtes ici:
